TrialThe Journal of infectious diseases2013

Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).

Dan H Barouch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.